Investigating the Effects of the SurroGait Rx™ Device on Postural Stability, Gait, and MSIS-29 Outcomes in People with Multiple #Sclerosis by Jordyn Vienneau in BJSTR

Abstract

The objective of this study was to investigate eight week training effects, followed by eight weeks of washout effects with a newly developed medical device (the SurroGait Rx™ [Orpyx Medical Technologies Inc., Calgary, Canada]) on physical and psychological impacts of #multiplesclerosis (MS), gait, and balance #parameters in individuals with MS. Seven individuals with MS completed the 16-week protocol, which included baseline, post-training (8 weeks) and post-washout (16 weeks) sessions. During each session, impact of MS on the patient (MSIS-29), gait (T25FW, stride variables), and balance (postural sway #trajectory) parameters were assessed. Results showed significant improvements in the MSIS-29 scores after training, no effect on #gaitvariables, and longer postural sway trajectories with the device on versus off. There were no significant training effects in the balance tasks. Future studies are warranted using individuals with more advanced cases of MS to more fully understand the potential benefits of the SurroGait Rx.

https://biomedres.us/abstracts/BJSTR.MS.ID.000689.php

https://biomedres.us/pdfs/BJSTR.MS.ID.000689.pdf

https://biomedres.us/fulltexts/BJSTR.MS.ID.000689.php

Investigating the Effects of the SurroGait Rx™ Device on Postural Stability, Gait, and MSIS-29 Outcomes in People with Multiple #Sclerosis by Jordyn Vienneau in BJSTR